Searching News Database: bladder cancer
HSMN NewsFeed - 7 Sep 2023
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
enGene Appoints Richard Bryce, MBChB, MRCGP, MFPM, as Chief Medical Officer
HSMN NewsFeed - 27 Sep 2021
Japan's MHLW Approves PADCEV(R) (enfortumab vedotin) for Advanced Urothelial Cancer
Japan's MHLW Approves PADCEV(R) (enfortumab vedotin) for Advanced Urothelial Cancer
HSMN NewsFeed - 19 Jul 2021
Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer
Nektar Appoints Dimitry S.A. Nuyten, M.D., Ph.D., as Senior Vice President and Chief Medical Officer
HSMN NewsFeed - 14 Jul 2021
First in Human Procedure with Vessi Medical's Cryotherapy System for Bladder Cancer
First in Human Procedure with Vessi Medical's Cryotherapy System for Bladder Cancer
HSMN NewsFeed - 26 Mar 2021
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
European Medicines Agency Accepts Marketing Authorization Application for Enfortumab Vedotin
HSMN NewsFeed - 31 Aug 2020
Vessi Medical Reaps $1.7 Million in Funding for Minimally Invasive Bladder Cancer Treatment
Vessi Medical Reaps $1.7 Million in Funding for Minimally Invasive Bladder Cancer Treatment
HSMN NewsFeed - 13 Feb 2020
Decipher GRID Signature Predicts Benefit from Chemotherapy in Men Diagnosed with Metastatic Prostate Cancer
Decipher GRID Signature Predicts Benefit from Chemotherapy in Men Diagnosed with Metastatic Prostate Cancer
HSMN NewsFeed - 12 Sep 2019
Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
Tocagen Reports Results of Toca 5 Phase 3 Trial in Recurrent Brain Cancer
HSMN NewsFeed - 31 Oct 2018
Shavit Capital Completes $100 Million Investment Round for Its Fifth Fund
Shavit Capital Completes $100 Million Investment Round for Its Fifth Fund
HSMN NewsFeed - 24 Sep 2018
Tocagen Appoints Mohamed Ladha as Vice President to Establish Commercial Organization
Tocagen Appoints Mohamed Ladha as Vice President to Establish Commercial Organization
HSMN NewsFeed - 19 Jun 2018
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
GenomeDx Biosciences and Pathnostics Launch Enhanced Version of Guidance Tests
HSMN NewsFeed - 16 May 2018
Photocure Announces Blue Light Cystoscopy with Cysview(R) Now Available for Surveillance of Bladder Cancer
Photocure Announces Blue Light Cystoscopy with Cysview(R) Now Available for Surveillance of Bladder Cancer
HSMN NewsFeed - 22 Feb 2018
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
GenomeDx Announces Inclusion of Decipher Genomic Testing in NCCN Guidelines for Prostate Cancer
HSMN NewsFeed - 16 Feb 2018
Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview(R)
Photocure Announces U.S. FDA Approval of New Indication for Blue Light Cystoscopy with Cysview(R)
HSMN NewsFeed - 9 May 2017
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
FDA Grants BAVENCIO(R) (avelumab) Approval for a Common Type of Advanced Bladder Cancer
HSMN NewsFeed - 6 Jan 2017
OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement
OncoGenex Pharmaceuticals, Inc. and Achieve Life Science, Inc. Announce Definitive Merger Agreement
HSMN NewsFeed - 5 Aug 2015
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
Mirati Therapeutics And MedImmune Partner On Immuno-Oncology Combination In Lung Cancer
HSMN NewsFeed - 30 Oct 2014
U.S. FDA Approves Once-Daily XIGDUO(TM) XR Tablets for Adults with Type 2 Diabetes
U.S. FDA Approves Once-Daily XIGDUO(TM) XR Tablets for Adults with Type 2 Diabetes
HSMN NewsFeed - 29 Jan 2014
Pacific Edge's Cxbladder(TM) Boosting Confidence in Bladder Cancer Detection
Pacific Edge's Cxbladder(TM) Boosting Confidence in Bladder Cancer Detection
HSMN NewsFeed - 17 Dec 2013
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
Heat Biologics, Inc. Appoints Dr. Anil K. Goyal as Vice President of Business Development
HSMN NewsFeed - 5 Sep 2013
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
GSK’s MAGE-A3 Cancer Immunotherapeutic Phase 3 Study in Melanoma Misses First Co-Primary Endpoint
HSMN NewsFeed - 26 Oct 2012
Tengion Provides Patient Update on its Neo-Urinary Conduit(TM) Clinical Program
Tengion Provides Patient Update on its Neo-Urinary Conduit(TM) Clinical Program
HSMN NewsFeed - 5 Apr 2012
Spectrum Pharmaceuticals Announces Results of Apaziquone Phase 3 Clinical Trials
Spectrum Pharmaceuticals Announces Results of Apaziquone Phase 3 Clinical Trials
HSMN NewsFeed - 24 Oct 2011
Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
Abbott's Genetic Test for Acute Myeloid Leukemia Prognosis Cleared by FDA
HSMN NewsFeed - 13 Sep 2011
Stellar Pharmaceuticals Receives European Approval for NeoVisc(R) Single Dose
Stellar Pharmaceuticals Receives European Approval for NeoVisc(R) Single Dose
HSMN NewsFeed - 27 Aug 2011
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
Abbott Receives FDA Approval for ALK Gene Test for Lung Cancer Therapy Selection
HSMN NewsFeed - 25 Jul 2011
TARIS Appoints Christopher Searcy as the Company’s Chief Business Officer
TARIS Appoints Christopher Searcy as the Company’s Chief Business Officer
HSMN NewsFeed - 15 Mar 2011
Breakthrough Light-Activated Drug-Device to be Investigated for Treatment of HPV* and Cervical Pre-cancer
Breakthrough Light-Activated Drug-Device to be Investigated for Treatment of HPV* and Cervical Pre-cancer
HSMN NewsFeed - 6 Jan 2011
Stellar Pharmaceuticals Annouces the Approval of Uracyst(R) by the KFDA in South Korea
Stellar Pharmaceuticals Annouces the Approval of Uracyst(R) by the KFDA in South Korea
HSMN NewsFeed - 21 Oct 2010
Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix Biliary Stents
Boston Scientific Announces FDA Clearance and CE Mark Approval for Advanix Biliary Stents
HSMN NewsFeed - 30 Jul 2010
Stellar Pharmaceuticals Inc. Signs Agreement for Distribution and Sale of Uracyst(R) in Spain
Stellar Pharmaceuticals Inc. Signs Agreement for Distribution and Sale of Uracyst(R) in Spain
HSMN NewsFeed - 26 May 2010
Predictive Biosciences Expands Leadership Team and Commercial Sales Force
Predictive Biosciences Expands Leadership Team and Commercial Sales Force
HSMN NewsFeed - 6 May 2010
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
HealthTronics Enters Into Definitive Merger Agreement With Endo Pharmaceuticals
HSMN NewsFeed - 5 May 2010
Stellar Pharmaceuticals Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Portugal
Stellar Pharmaceuticals Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Portugal
HSMN NewsFeed - 9 Apr 2010
Stellar Pharmaceuticals Announces Steven H. Goldman Rejoins Board of Directors
Stellar Pharmaceuticals Announces Steven H. Goldman Rejoins Board of Directors
HSMN NewsFeed - 18 Feb 2010
BSD Medical Announces First Swiss Installation of the BSD-2000/3D Hyperthermia System at Kantonsspital Aarau
BSD Medical Announces First Swiss Installation of the BSD-2000/3D Hyperthermia System at Kantonsspital Aarau
HSMN NewsFeed - 24 Nov 2009
MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre
MDRNA Expands RNAi Bladder Cancer Program With the Vancouver Prostate Centre
HSMN NewsFeed - 30 Oct 2009
Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival
Global Phase III Study Results Show Eribulin Meets Primary Endpoint of Overall Survival
HSMN NewsFeed - 21 Jul 2009
FDA Designates Fast Track Status for Apaziquone (EOquin(R)) for Bladder Cancer
FDA Designates Fast Track Status for Apaziquone (EOquin(R)) for Bladder Cancer
HSMN NewsFeed - 10 Jul 2009
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
Bioniche Life Sciences Inc. and Endo Pharmaceuticals Sign Licensing Agreement for Urocidin(TM)
HSMN NewsFeed - 5 May 2009
Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Italy
Stellar Pharmaceuticals Inc. Signs Licensing Agreement for Distribution and Sale of Uracyst(R) in Italy
HSMN NewsFeed - 12 Mar 2009
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
FDA Accepts Complete Response Submission to New Drug Application for NEBIDO(R)
HSMN NewsFeed - 29 Jan 2009
Polymedco Introduces Point of Care Test for Recurrent Bladder Cancer Detection
Polymedco Introduces Point of Care Test for Recurrent Bladder Cancer Detection
HSMN NewsFeed - 5 Jan 2009
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
Indevus Pharmaceuticals Announces Definitive Merger Agreement With Endo Pharmaceuticals
HSMN NewsFeed - 24 Nov 2008
NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer
NCCN Receives $1.5 Million Grant to Research Targeted Therapy in Bladder Cancer
HSMN NewsFeed - 11 Nov 2008
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
Cardium's InnerCool Announces New Tissue-Specific UroCool(TM) System for Use in Prostate Surgeries
HSMN NewsFeed - 28 Oct 2008
Ikonisys Receives FDA Clearance for Non-Invasive, HER-2 Breast Cancer Test
Ikonisys Receives FDA Clearance for Non-Invasive, HER-2 Breast Cancer Test
HSMN NewsFeed - 26 Sep 2008
Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
Indevus Announces Agreement With Teva to Develop Pagoclone for the Treatment of Stuttering
HSMN NewsFeed - 16 Jul 2008
Predictive Biosciences Expands Executive Leadership Team with Two Diagnostic Industry Veteran Appointments
Predictive Biosciences Expands Executive Leadership Team with Two Diagnostic Industry Veteran Appointments
HSMN NewsFeed - 22 May 2008
Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.
Indevus Pharmaceuticals Licenses Canadian Rights for SANCTURA XR(TM) to Allergan, Inc.
HSMN NewsFeed - 3 Mar 2008
Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
Indevus Pharmaceuticals Announces Retirement Plans For Its CEO and Chairman
HSMN NewsFeed - 13 Feb 2008
Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
Bioniche Provides Update on Refractory Bladder Cancer Trial with Urocidin(TM)
HSMN NewsFeed - 23 Nov 2007
Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
Bristol-Myers Squibb and Pierre Fabre Provide Update On Vinflunine Development Status
HSMN NewsFeed - 11 Sep 2007
Stellar Pharmaceuticals Agrees to Settle Dispute with European Uracyst Licensee
Stellar Pharmaceuticals Agrees to Settle Dispute with European Uracyst Licensee
HSMN NewsFeed - 17 Aug 2007
Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
Indevus Receives Approvable Letter From FDA for VALSTAR(R) for Bladder Cancer Therapy
HSMN NewsFeed - 16 Aug 2007
Pro-Pharmaceuticals Announces ''Compassionate Use'' IND for DAVANAT(R) to Treat Biliary Cancer Patient
Pro-Pharmaceuticals Announces ''Compassionate Use'' IND for DAVANAT(R) to Treat Biliary Cancer Patient
HSMN NewsFeed - 27 Jul 2007
Marketing Authorization Application for Satraplatin Accepted for Review by the European Medicines Agency
Marketing Authorization Application for Satraplatin Accepted for Review by the European Medicines Agency
HSMN NewsFeed - 29 Jun 2007
Indevus Appoints Industry Veteran Kurt Lewis as Senior Vice President Sales & Marketing
Indevus Appoints Industry Veteran Kurt Lewis as Senior Vice President Sales & Marketing
HSMN NewsFeed - 25 Jun 2007
Indevus Announces Launch of SUPPRELIN(R) LA for Central Precocious Puberty
Indevus Announces Launch of SUPPRELIN(R) LA for Central Precocious Puberty
HSMN NewsFeed - 21 Jun 2007
Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
Abbott's RealTime Hepatitis B Viral Load Test Receives CE Marking in Europe
HSMN NewsFeed - 31 May 2007
Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
Indevus Announces Authorization for Approval of VANTAS(R) in Selected European Countries
HSMN NewsFeed - 25 Apr 2007
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
Alkermes and Indevus Announce Initiation of Phase 2a Clinical Study of ALKS 27 for the Treatment of COPD
HSMN NewsFeed - 19 Apr 2007
Indevus Announces Submission of Supplemental NDA to Reintroduce VALSTAR(R) to Treat Bladder Cancer
Indevus Announces Submission of Supplemental NDA to Reintroduce VALSTAR(R) to Treat Bladder Cancer
HSMN NewsFeed - 17 Apr 2007
Cook Medical Launches Full Line of Resection Electrodes Enabling Urologists to Improve Prostate Health
Cook Medical Launches Full Line of Resection Electrodes Enabling Urologists to Improve Prostate Health
HSMN NewsFeed - 11 Apr 2007
Polymedco Introduces Point of Care Test for Recurrent Bladder Cancer Detection
Polymedco Introduces Point of Care Test for Recurrent Bladder Cancer Detection
HSMN NewsFeed - 25 Jan 2007
Bayer Discontinues Trasylol(R) Clinical Trial Program in Non-CABG Indications
Bayer Discontinues Trasylol(R) Clinical Trial Program in Non-CABG Indications
HSMN NewsFeed - 25 Jan 2007
FDA Clears BioView Duet(TM) System for Automated FISH Scanning of Breast Cancer Tissue Specimens
FDA Clears BioView Duet(TM) System for Automated FISH Scanning of Breast Cancer Tissue Specimens
HSMN NewsFeed - 26 Dec 2006
IDM Pharma Announces Acceptance for Review of the NDA for Junovan(TM) (Mifamurtide)
IDM Pharma Announces Acceptance for Review of the NDA for Junovan(TM) (Mifamurtide)
HSMN NewsFeed - 27 Nov 2006
Cytokinetics and GlaxoSmithKline Amend Collaboration and License Agreement
Cytokinetics and GlaxoSmithKline Amend Collaboration and License Agreement
HSMN NewsFeed - 8 Nov 2006
First Patient Treated in Bioniche Phase III Refractory Bladder Cancer Trial
First Patient Treated in Bioniche Phase III Refractory Bladder Cancer Trial
HSMN NewsFeed - 27 Jun 2006
Cameron Groome Joins Bioniche as Executive Vice-President, Corporate & Strategic Development
Cameron Groome Joins Bioniche as Executive Vice-President, Corporate & Strategic Development
HSMN NewsFeed - 24 May 2006
Valera Pharmaceuticals Appoints Jeremy D. Middleton To The Position Of Vice President, Business Development
Valera Pharmaceuticals Appoints Jeremy D. Middleton To The Position Of Vice President, Business Development
HSMN NewsFeed - 24 May 2006
Studies Presented at American Urological Association Expand the Role of the NMP22(R) BladderChek(R) Test
Studies Presented at American Urological Association Expand the Role of the NMP22(R) BladderChek(R) Test
HSMN NewsFeed - 23 May 2006
Matritech's NMP22(R) BladderChek(R) Test Can Assist in Early Identification of High Risk Tumors
Matritech's NMP22(R) BladderChek(R) Test Can Assist in Early Identification of High Risk Tumors
Additional items found! 184
Members Archive contains
184 additional stories matching:
bladder cancer
(Password required)
bladder cancer
(Password required)